NCT06424470View on ClinicalTrials.gov

Study on the Treatment of Prurigo Nodularis With Stapokibart Injection

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 25, 2024

Primary Completion Date

July 30, 2026

Study Completion Date

July 30, 2026

Conditions
Prurigo Nodularis
Interventions
BIOLOGICAL

Stapokibart

Stapokibart Injection

OTHER

Placebo

Placebo

Trial Locations (1)

Unknown

The First Hospital of China Medical University, Shenyang

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT06424470 - Study on the Treatment of Prurigo Nodularis With Stapokibart Injection | Biotech Hunter | Biotech Hunter